Björklund Pharma’s biotech programs focus on mechanism-based approaches to tissue repair, neuroprotection, and redox balance in chronic and severe conditions.
Regenerative Medicine
Regenerative medicine programs focus on restoring function and healing in chronic and severe conditions, including injuries and degenerative disorders. Björklund Pharma explores thymosin beta-4 and biofactor-based products as potential ways to enhance recovery and healing. Read More
Psychiatry
Fabomotizole (4-[2-[(6-ethoxy-1H-benzimidazol-2-yl)sulfanyl]ethyl]morpholine) is an anxiolytic drug under investigation for its anxiolytic and neuroprotective properties. It is characterized by a low propensity for sedative, hypnotic, or muscle-relaxant effects in experimental and clinical studies. Read More
Redox and Metal Chelation (BDTH2)
BDTH2 (N,N′-bis-(2-mercaptoethyl) isophthalamide, NBMI, emeramide) is a thiol-redox antioxidant and metal chelator designed to penetrate cell membranes and cross the blood–brain barrier. BDTH2 can scavenge hydroxyl free radicals and modulate the toxicity of reactive oxygen species, which may disrupt the normal redox status of cells. The compound is being evaluated in relation to oxidative stress and heavy metal exposure, with the aim of supporting cellular redox balance and recovery. Read More